XML 17 R7.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Cash flows from operating activities    
Net loss $ (28,370) $ (17,490)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 7,814 2,877
Amortization of debt discount and issuance costs 2,870 285
Non-cash operating lease expense 965 741
Investment discount and premium amortization 417 (6)
Provision for expected credit losses 300 51
Stock-based compensation expense 13,510 8,741
Deferred tax provision (benefit) 2 (1,280)
Change in fair value of contingent consideration liabilities 2,156 (359)
Other (34) (4)
Change in operating assets and liabilities:    
Accounts receivable, net 2,090 (7,335)
Deferred costs 0 444
Prepaid expenses and other assets (2,173) (2,244)
Accounts payable, accrued liabilities, and other liabilities (5,352) (4,283)
Deferred revenue 3,745 3,936
Operating lease liabilities (1,083) (843)
Net cash used in operating activities (3,143) (16,769)
Cash flows from investing activities    
Purchases of property and equipment (5,882) (428)
Capitalization of internal-use software (887) (78)
Proceeds from the sale of property and equipment 6 6
Purchase of short-term investments (8,621) 0
Proceeds from the sale and maturity of short-term investments 53,240 66,653
Purchase of intangible assets (480) (758)
Acquisition of business, net of cash acquired 0 (15,249)
Net cash provided by investing activities 37,376 50,146
Cash flows from financing activities    
Proceeds from exercise of stock options 6,488 9,046
Proceeds from employee stock purchase plan 1,349 1,289
Payments of acquisition-related consideration (1,391) (748)
Net cash provided by financing activities 6,446 9,587
Effect of exchange rate changes on cash and cash equivalents (6) (31)
Net increase in cash and cash equivalents 40,673 42,933
Cash and cash equivalents at beginning of period 91,954 18,032
Cash and cash equivalents at end of period 132,627 60,965
Supplemental disclosures of non-cash investing and financing information    
Purchase of property and equipment included in accounts payable and accrued liabilities 1,816 77
Common stock issued for settlement of contingent consideration 1,009 0
Common stock issued in connection with acquisitions 0 3,332
Stock-based compensation capitalized as internal-use software 130 0
Deferred offering costs included in accounts payable and accrued liabilities 0 427
Purchase of intangible assets included in accounts payable and accrued liabilities $ 0 $ 132